News

• Gritstone Announces Promotions Within its Leadership Team
  03/08/2021 / 14:00 - GlobeNewswire
•  
• Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2020 Financial Results and Recent Corporate Developments
  03/01/2021 / 22:05 - GlobeNewswire
•  
• Dyve Biosciences Appoints Camilla V. Simpson to Board of Directors
  02/01/2021 / 14:00 - GlobeNewswire
•  
• Pliant Therapeutics Announces Appointment of David Pyott to Board of Directors
  01/12/2021 / 14:00 - GlobeNewswire
•  
• Peloton, Marvell added to Nasdaq 100 index
  12/14/2020 / 14:45 - TeleTrader
•  
• Annual Changes to the Nasdaq-100 Index
  12/12/2020 / 02:05 - GlobeNewswire
•  
• BMRN Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds BioMarin Pharmaceutical Inc. Investors With Losses Exceeding $100K of Class Action and Lead Plaintiff Deadline: November 24, 2020
  11/24/2020 / 16:00 - GlobeNewswire
•  
• BMRN FINAL DEADLINE NOTICE: ROSEN, GLOBAL INVESTOR COUNSEL, Reminds BioMarin Pharmaceutical Inc. Investors of Important Tuesday Deadline in Securities Class Action – BMRN
  11/23/2020 / 18:00 - GlobeNewswire
•  
• BioMarin Pharmaceutical, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit: Portnoy Law Firm
  11/20/2020 / 14:00 - GlobeNewswire
•  
• BMRN ALERT NOV. 24 DEADLINE - Pawar Law Group Announces a Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.
  11/19/2020 / 17:07 - GlobeNewswire
•  
• GLNG & BMRN Deadlines: Bronstein, Gewirtz & Grossman LLC Reminds Shareholders of Class Actions and Upcoming Lead Plaintiff Deadlines
  11/18/2020 / 17:00 - GlobeNewswire
•  
• SHAREHOLDER ALERT: CLAIMSFILER REMINDS BMRN, BTU, CACC, GOCO INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
  11/17/2020 / 04:50 - GlobeNewswire
•  
• IMMINENT SHAREHOLDER DEADLINE: BioMarin Pharmaceutical, Inc. Sued for Violations of the Federal Securities Laws; Investors Who Lost Money Should Contact Block & Leviton LLP Before November 24, 2020
  11/16/2020 / 17:07 - GlobeNewswire
•  
• BMRN UPCOMING DEADLINE: Zhang Investor Law Alerts Investors to Imminent Deadline in Securities Class Action Lawsuit Against  BioMarin Pharmaceutical Inc. – BMRN
  11/13/2020 / 15:56 - GlobeNewswire
•  
• IMPORTANT NOV. 24 DEADLINE – BMRN - Pawar Law Group Announces a Securities Class Action Lawsuit Against BioMarin Pharmaceutical Inc.
  11/12/2020 / 21:56 - GlobeNewswire